Amarin | AMRN - DÍVIDA





DÍVIDA Alterar Data
AbbVie USD 1000K 70.48B 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amarin USD 0 0 2025-03
AstraZeneca USD 32.63B 207M 2025-09
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
DBV Technologies USD 8.59M 295K 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Novartis USD 32.64B 1.37B 2025-06